SARS-CoV-2NeutralizingAntibody Test DIXION (Fluorescence immunoassay)

The kit is used to detect the neutralizing antibody to SARS-CoV-2 in human serum, plasma or whole blood sample quantitatively.
It is mainly used to identify individuals with acquired immune response to the SARS-CoV-2, and to evaluate the effectiveness of
the vaccine clinical trials and mass vaccination.

Sample types: whole blood, plasma, serum
Reaction Time: 15 mins
Results: quantitative

NAbs were detected from day 4 to day 6 after symptom onset and
peaked at day 10 to day 15
NAbs can be found in persons who have recovered from COVID-19
NAbs could help determine the optimal design and dosing of
vaccines
NAbs could help determine whether people needs the first
vaccination and the necessity and time point of Second vaccination

ANALYZER PARAMETERS

Product name Fluorescence Immunoassay Analyzer
Model DIXION-DP-110, DIXION-DP-112, DIXION-DP-113
Methodology Time-resolved fluorescence immunoassay (TRFIA)
Test mode Automatic mode, Manual mode, Following mode, Continuous mode
Storage Up to 40000 test results
Communication Connecting to LIS by COM or USB etc.
Printing

 

Built-in thermal printer, external printer optional

 

Port

 

Serial Port, USB, Bluetooth (Wireless module),

Ethernet

 

Detection speed

 

Under continuous mode, up to 200 tests/hour
Sample type

 

Whole blood, serum, plasma or body fluids

 

Size

 

230mm*170mm*305mm

 

Weight

 

About 2.4kg

 

 

Basic service